BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 22457183)

  • 1. [Erratum to: Tyrosin kinase inhibitors in oncology.].
    Zander T; Hallek M
    Internist (Berl); 2011 Jul; ():. PubMed ID: 21744149
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of Tertiary Lymphoid Structures on Prognosis of Patients with Hepatocellular Carcinoma and Preliminary Exploration of Its Formation Mechanism.
    Li J; Nie Y; Jia W; Wu W; Song W; Li Y
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the application of inflammatory biomarkers in epidemiologic cancer research.
    Brenner DR; Scherer D; Muir K; Schildkraut J; Boffetta P; Spitz MR; Le Marchand L; Chan AT; Goode EL; Ulrich CM; Hung RJ
    Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1729-51. PubMed ID: 24962838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow micrometastasis is associated with both disease recurrence and poor survival in surgical patients with node-negative non-small-cell lung cancer: a meta-analysis.
    Deng XF; Liu QX; Zhou D; Min JX; Dai JG
    Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):21-7. PubMed ID: 25883247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage I non-small cell lung cancer: the presence of the lymphocyte-specific protein tyrosin kinase in the tumour infiltrate is associated with a better long-term prognosis.
    D'Andrilli A; Natoli G; Scarpino S; Rendina EA
    Interact Cardiovasc Thorac Surg; 2012 Jul; 15(1):148-51. PubMed ID: 22457183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine-protein phosphatase non-receptor type 12 expression is a good prognostic factor in resectable non-small cell lung cancer.
    Cao X; Chen YZ; Luo RZ; Zhang L; Zhang SL; Zeng J; Jiang YC; Han YJ; Wen ZS
    Oncotarget; 2015 May; 6(13):11704-13. PubMed ID: 25868976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.
    Carr SR; Schuchert MJ; Pennathur A; Wilson DO; Siegfried JM; Luketich JD; Landreneau RJ
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):390-7. PubMed ID: 22169444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time trend of mediastinal lymph node dissection in stage IA non-small cell lung cancer patient who undergo lobectomy: a retrospective study of surveillance, epidemiology, and end results (SEER) database.
    Pan L; Mo R; Zhu L; Yu W; Lv W; Hu J
    J Cardiothorac Surg; 2020 Aug; 15(1):207. PubMed ID: 32738925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.
    Shien K; Toyooka S; Soh J; Okami J; Higashiyama M; Kadota Y; Maeda H; Hayama M; Chida M; Funaki S; Okumura M; Miyoshi S
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):791-6. PubMed ID: 25805399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
    Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
    J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new lung cancer staging system.
    Detterbeck FC; Boffa DJ; Tanoue LT
    Chest; 2009 Jul; 136(1):260-271. PubMed ID: 19584208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXP3 expression and overall survival in breast cancer.
    Merlo A; Casalini P; Carcangiu ML; Malventano C; Triulzi T; Mènard S; Tagliabue E; Balsari A
    J Clin Oncol; 2009 Apr; 27(11):1746-52. PubMed ID: 19255331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Lck-derived peptides applicable to anti-cancer vaccine for patients with human leukocyte antigen-A3 supertype alleles.
    Naito M; Komohara Y; Ishihara Y; Noguchi M; Yamashita Y; Shirakusa T; Yamada A; Itoh K; Harada M
    Br J Cancer; 2007 Dec; 97(12):1648-54. PubMed ID: 18043580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A five-gene signature and clinical outcome in non-small-cell lung cancer.
    Chen HY; Yu SL; Chen CH; Chang GC; Chen CY; Yuan A; Cheng CL; Wang CH; Terng HJ; Kao SF; Chan WK; Li HN; Liu CC; Singh S; Chen WJ; Chen JJ; Yang PC
    N Engl J Med; 2007 Jan; 356(1):11-20. PubMed ID: 17202451
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.